Clinical Trial Update: Evaluation of Platelet Aggregability in Patients with Non-small Cell Lung Carcinomas [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial conducted by the University of Sao Paulo is evaluating platelet aggregability in patients with non-small cell lung cancer and is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University of Sao Paulo | Conditions: Assessment of Platelet Aggregability in Patients Patients with Non-small Cell Lung Carcinoma | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING